William J. Fallon, Vice President, CMC Operations and Strategic Alliances

Mr. William Fallon joined Halozyme in 2006 as Vice President, Manufacturing & Operations. His responsibilities have expanded during his tenure at Halozyme and now include oversight of all aspects of internal and external manufacturing, supply chain, quality assurance, quality control and facilities operations, as well as bioprocess development. Most recently he assumed additional responsibility to lead Halozyme’s cross-functional team managing strategy and operations for the ENHANZE® business, including direct management of strategic alliances.

Prior to Halozyme, he served as President and Chief Executive Officer of Cytovance Biologics, a contract manufacturing organization that provides manufacturing and development services to the biotechnology industry. From 2001 to 2003, he was Vice President of Technical Operations at Genzyme Corporation, having held the same position at Novazyme Pharmaceuticals, Inc. prior to its acquisition by Genzyme in 2001. Mr. Fallon joined Novazyme from Transkaryotic Therapies, where he was Vice President of Manufacturing from 1998 to 2001. From 1993 to 1998, he was employed in several management positions for the Ares-Serono Group, including Vice President, U.S. Manufacturing Operations. In this role, he served as general manager, overseeing the production and distribution of all of Serono's approved biotechnology products in the U.S. From 1990 to 1992, he was Director of Manufacturing for Centocor, Inc. His prior experience also includes various management and operational roles at Invitron Corporation and Travenol-Genentech Diagnostics. Mr. Fallon earned a B.S. in Marine Science and a B.A. in Biology from Long Island University, and an M.S. in Biology from Northeastern University.


You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.